Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

bosutinib 500 MG Oral Tablet [Bosulif]

Known as: BOSUTINIB MONOHYDRATE 500 mg ORAL TABLET, FILM COATED [BOSULIF], Bosulif 500 MG (bosutinib monohydrate 516.98 MG) Oral Tablet, Bosulif 500 MG Oral Tablet 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
 
Is this relevant?
Review
2016
Review
2016
要約:慢性骨髄性白血病(CML)患者の 95%以上で発 現している Bcr-Abl融合遺伝子は,その恒常的な活性 化が白血病細胞の増殖に関与しており,Bcr-Ablチロ シンキナーゼは CML… Expand
Is this relevant?
Review
2015
Review
2015
Dear editor Miller et al1 recently reviewed the role of ponatinib in chronic myeloid leukemia (CML) and Philadelphia… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Review
2013
Review
2013
Bosutinib (Bosulif®) is an orally administered small molecule tyrosine kinase inhibitor (TKI) of BCR–ABL and SRC family kinases… Expand
  • table 1
  • table 2
  • figure 1
Is this relevant?